Dexamethasone

Key facts

Active substance
dexamethasone
Therapeutic area
Ophthalmology
Decision number
P/44/2009
PIP number
Dexamethasone
Pharmaceutical form(s)
Intravitreal implant in applicator
Condition(s) / indication(s)
Chronic non-infectious intermediate or posterior uveitis
Route(s) of administration
Intravitreal use
Contact for public enquiries
Allergan Pharmaceuticals International Limited

E-mail: ml-eu_reg_affairs@allergan.com
Tel. +44 (0)1628 4944444

Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating